ADHERA THERAPEUTICS, INC.

Profile

Company Names

ADHERA THERAPEUTICS, INC.
MARINA BIOTECH, INC.

Addresses

BOX 2161, WAKE FOREST, NC 27588

4721 EMPEROR BLVD., SUITE 350, DURHAM, NC 27703

17870 CASTLETON STREET, SUITE 250, CITY OF INDUSTRY, CA 91748

BOX 1559, BOTHELL, WA 98041

3830 MONTE VILLA PARKWAY, BOTHELL, WA 98021

Phone Numbers

919-578-5901
919-518-3748
626-964-5788
425-892-4322
(425) 908-3600

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$65,782,524.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2019-06-28 
$499,950.00 
$499,950.00 
$0.00 
Debt 
8
2018-07-12 
$1,540,000.00 
$11,000,000.00 
$9,460,000.00 
Equity 
7
2018-04-16 
$11,670,000.00 
$15,000,000.00 
$3,330,000.00 
Equity 
6
2017-06-05 
$500,000.00 
$500,000.00 
$0.00 
Debt 
5
2016-06-21 
$300,000.00 
$300,000.00 
$0.00 
Debt 
4
2015-08-07 
$1,100,000.00 
$1,100,000.00 
$0.00 
Equity 
3
2014-03-07 
$6,000,000.00 
$6,000,000.00 
$0.00 
Equity 
2
2011-12-29 
$172,574.00 
$5,172,574.00 
$5,000,000.00 
Equity 
1
2010-07-21 
$44,000,000.00 
$44,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ISSAC 
 
BLECH 
DIRECTOR
TIM 
 
BORIS 
DIRECTOR
PHILIPPE 
 
CALAIS 
DIRECTOR
ERIK 
 
EMERSON 
EXECUTIVE OFFICER, DIRECTOR
R. 
JOHN 
FLETCHER 
DIRECTOR
J. 
MICHAEL 
FRENCH 
EXECUTIVE OFFICER, DIRECTOR
PETER 
S. 
GARCIA 
EXECUTIVE OFFICER
ULI 
 
HACKSELL 
DIRECTOR
RICHARD 
T. 
HO 
EXECUTIVE OFFICER
JAMES 
M. 
KARIS 
DIRECTOR
CHIANG 
J. 
LI 
DIRECTOR
STEFAN 
 
LOREN 
DIRECTOR
ROBERT 
C. 
MOSCATO 
EXECUTIVE OFFICER, DIRECTOR
NANCY 
 
PHELAN 
EXECUTIVE OFFICER, DIRECTOR
BARRY 
 
POLISKY 
EXECUTIVE OFFICER
JOSEPH 
W. 
RAMELLI 
DIRECTOR, EXECUTIVE OFFICER
PHILIP 
C. 
RANKER 
EXECUTIVE OFFICER, DIRECTOR
GREGORY 
 
SESSLER 
DIRECTOR
RHONDA 
 
STANLEY 
EXECUTIVE OFFICER
MICHAEL 
D. 
TAYLOR 
DIRECTOR
VUONG 
 
TRIEU 
DIRECTOR, EXECUTIVE OFFICER
DONALD 
A. 
WILLIAMS 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2019-06-28 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2019-06-28 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-07-12 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-04-16 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2017-06-05 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2017-06-05 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2016-06-21 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-08-07 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-03-07 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-12-29 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2010-07-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MAXIM GROUP LLC
NONE
NONE
NONE
NONE
NONE
NONE
MONTECITO ADVISORS, INC.
NONE
NONE
CANACCORD GENUITY INC.